Generic Drug Product Development in Japan: Regulatory Updates During 2014–2019 and the Future Miho KasugaRyosuke KuribayashiMitsue Hirota Current Opinion 29 September 2021 Pages: 711 - 719
A Systematic Review of Multiple Linear Regression-Based Limited Sampling Strategies for Mycophenolic Acid Area Under the Concentration–Time Curve Estimation Joanna SobiakMatylda Resztak Systematic Review Open access 04 September 2021 Pages: 721 - 742
Advances in Thiopurine Drug Delivery: The Current State-of-the-Art Ahmed B. BayoumyFemke CrouwelNanne K. H. de Boer Review Article Open access 06 September 2021 Pages: 743 - 758
Pharmacokinetics, Tolerability, and Safety of Single and Multiple Omecamtiv Mecarbil Doses in Healthy Japanese and Caucasian Subjects Ashit TrivediFady I. MalikEdward Lee Original Research Article 20 August 2021 Pages: 759 - 770
Pharmacokinetics of Synthetic Cathinones Found in Bath Salts in Mouse Brain and Plasma Using High-Pressure Liquid Chromatography–Tandem Mass Spectrometry Courtney GearldsJessica Brooke BouldinBrooks B. Pond Original Research Article 24 August 2021 Pages: 771 - 778
Physiologically-Based Pharmacokinetic Modelling of Entrectinib Parent and Active Metabolite to Support Regulatory Decision-Making Nassim DjebliVincent BuchheitGeorgina Meneses-Lorente Original Research Article 08 September 2021 Pages: 779 - 791
Pharmacokinetic Properties of S-oxiracetam After Single and Multiple Intravenous Infusions in Healthy Volunteers Dahu LiangJie ShenHua Sun Original Research Article 21 September 2021 Pages: 793 - 805
Population Pharmacokinetic Analysis from First-in-Human Data for HDAC Inhibitor, REC-2282 (AR-42), in Patients with Solid Tumors and Hematologic Malignancies: A Case Study for Evaluating Flat vs. Body Size Normalized Dosing Sophia LivaMin ChenMitch A. Phelps Original Research Article Open access 07 October 2021 Pages: 807 - 816
Severe 5-Fluorouracil-Associated Gastrointestinal Toxicity Unexplained by Dihydropyrimidine Dehydrogenase Deficiency and Renal Impairment: Should We Be Investigating Other Elimination Pathways to Assess the Risk of 5-Fluorouracil Toxicity? Soo Hee JeongOttiniel ChavaniNuala Helsby Research Letter 27 September 2021 Pages: 817 - 820
Oral Antibiotics in Patients with Short Bowel Syndrome: Do or Don’t? Michelle GompelmanNynke G. L. JagerGeert J. A. Wanten Letter to the Editor 07 September 2021 Pages: 821 - 823
Oral Antibiotics in Patients with Short Bowel Syndrome: Hurdles and Caveats Lawrence Siu-Chun LawWallace Bok-Thoe HongElaine Ah-Gi Lo Letter to Editor 05 October 2021 Pages: 825 - 826
Correction to: Identifying Safety Thresholds for Immunosuppressive Drugs: Applying Insights from Primary Antibody Deficiencies to Mitigate Adverse Events in Secondary Antibody Deficiencies Using Mathematical Modeling of Preclinical and Early Clinical Data Irina KarevaAnup ZutshiOrestis Papasouliotis Correction Open access 28 September 2021 Pages: 827 - 827
